HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Crystal Kantores Selected Research

Y 27632

6/2015Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
1/2014Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.
12/2010Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
2/2008Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Crystal Kantores Research Topics

Disease

14Pulmonary Hypertension (Ayerza Syndrome)
06/2015 - 06/2005
12Anoxia (Hypoxia)
06/2015 - 11/2006
9Lung Injury
07/2015 - 09/2009
6Hypercapnia
04/2014 - 11/2006
5Bronchopulmonary Dysplasia
03/2015 - 09/2009
4Right Ventricular Hypertrophy
01/2014 - 12/2010
3Inflammation
03/2015 - 07/2012
1Body Weight (Weight, Body)
10/2014
1Pneumonia (Pneumonitis)
01/2014
1Right Ventricular Dysfunction
11/2010
1Cardiomegaly (Heart Hypertrophy)
11/2010
1Hyperoxia
11/2009
1Acidosis
11/2006
1Hyperplasia
06/2005

Drug/Important Bio-Agent (IBA)

7Peroxynitrous Acid (Peroxynitrite)IBA
07/2015 - 11/2009
6rho-Associated KinasesIBA
06/2015 - 02/2008
6Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2014 - 02/2008
4Y 27632IBA
06/2015 - 02/2008
4Bleomycin (Blenoxane)FDA LinkGeneric
03/2015 - 02/2008
4Carbon MonoxideIBA
07/2012 - 11/2006
33-nitrotyrosineIBA
11/2010 - 02/2008
3Endothelins (Endothelin)IBA
11/2006 - 06/2005
2Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
06/2015 - 11/2010
2fasudil (AT 877)IBA
06/2015 - 02/2008
2ArginaseIBA
03/2015 - 10/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2014 - 07/2012
2Superoxides (Superoxide)IBA
08/2013 - 02/2008
28-epi-prostaglandin F2alphaIBA
11/2006 - 09/2006
1Secretory Proteinase Inhibitory ProteinsIBA
07/2015
1Leukocyte Elastase (Neutrophil Elastase)IBA
07/2015
1ElastinIBA
07/2015
1CollagenIBA
03/2015
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2015
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
10/2014
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2014
1Nitric Oxide Synthase (NO Synthase)IBA
04/2014
1InterleukinsIBA
04/2014
11- (2- bromophenyl)- 3- (7- cyano- 3H- benzotriazol- 4- yl)ureaIBA
01/2014
15'-Guanylic Acid (GMP)IBA
06/2012
1OxygenIBA
03/2011
1Small Interfering RNA (siRNA)IBA
12/2010
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
11/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2009
1Tyrosine (L-Tyrosine)FDA Link
11/2009
1Angiopoietin-1IBA
11/2009
115-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
10/2009
1Interleukin-1 (Interleukin 1)IBA
09/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
09/2009
1Xanthine OxidaseIBA
02/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2008
1Allopurinol (Remid)FDA LinkGeneric
02/2008
1tempolIBA
02/2008
1Carbon DioxideIBA
11/2006
1Endothelin-1 (Endothelin 1)IBA
11/2006
1Prostaglandin H2 Thromboxane A2 ReceptorsIBA
09/2006
1AntioxidantsIBA
09/2006
1platelet-derived growth factor BB (becaplermin)FDA Link
06/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2005
1DNA (Deoxyribonucleic Acid)IBA
06/2005

Therapy/Procedure

1Parenteral Nutrition
03/2011
1Subcutaneous Injections
12/2010